SCHEMBL15032610

SCHEMBL15032610

CCCCCn1c(NC(=O)c2ccc(Br)o2)c(C#N)c2nc3ccccc3nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SAE1 Q9UBE0 9/20 0.72
UBA2 Q9UBT2 9/20 0.72
KDM4E B2RXH2 11/20 0.68
CASP1 P29466 8/20 0.68
HSD17B10 Q99714 8/20 0.68
MEN1 O00255 8/20 0.68
KMT2A Q03164 8/20 0.68
BLM P54132 7/20 0.68
NSD2 O96028 5/20 0.68
POLB P06746 4/20 0.68
LMNA P02545 4/20 0.68
ALOX15 P16050 3/20 0.68
NPSR1 Q6W5P4 3/20 0.68
RECQL P46063 3/20 0.68
TP53 P04637 2/20 0.68
HSP90AA1 P07900 2/20 0.68
CASP6 P55212 2/20 0.68
HSP90AB1 P08238 1/20 0.68
ALOX12 P18054 1/20 0.68
MAPK1 P28482 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15032605 0.97 SAE1 (0.76) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL4787894 0.91 KDM4E (0.68) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL15256874 0.84 SAE1 (1.00) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL8147117 0.84 KDM4E (0.75) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL4787299 0.81 KDM4E (0.72) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL4787869 0.81 SAE1 (1.00) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL4787907 0.81 SAE1 (0.94) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL15256907 0.80 SAE1 (1.00) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL15256873 0.79 SAE1 (0.87) SAE1UBA2KDM4ECASP1HSD17B10
SCHEMBL4787545 0.78 SAE1 (1.00) SAE1UBA2KDM4ECASP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073941-B2 Compounds and methods for treating tuberculosis infection ACADEMIA SINICA (TW) 2015-07-07 US disclosed
US-9073941-B2 Compounds and methods for treating tuberculosis infection ACADEMIA SINICA (TW) 2015-07-07 US disclosed
US-20130158037-A1 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS INFECTION ACADEMIA SINICA (TW) 2013-06-20 US disclosed
US-20130158037-A1 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS INFECTION ACADEMIA SINICA (TW) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158037-A1 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS INFECTION TALDO1, PGD, DLD SAE1 2017/4885UBA2 2986/4885KDM4E 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.